Ziel
Hypoxic pulmonary vasoconstriction (HPV) is a unique vasoconstrictor response that diverts blood flow away from poorly ventilated lung regions allowing ventilation-perfusion matching. Despite being a highly conserved adaptive physiological mechanism in lung breathing vertebrates that optimizes blood oxygen saturation, hypoxia sensing in the lung plays a critical pathophysiological role in a number of pulmonary disorders. COPD is associated with chronic hypoxia and can lead in some patients to secondary pulmonary hypertension (PH). Where COPD is confounded with PH, patients have a worse prognosis for survival. In contrast, failure of HPV is often a critical determinant of hypoxemia in sepsis- and trauma-induced lung injury, including the acute respiratory distress syndrome (ARDS). Despite intensive research in the field, the molecular bases of HPV are far from being elucidated. We have recently shown that ceramide production derived from neutral sphingomyelinase (nSMase) and subsequent activation of PKCz are early and necessary events in the signaling cascade of HPV. In sepsis/ARDS an acidic form of SMase is induced. This form can deplete the downstream signaling components of nSMase and is associated with inflammation. Inhibition of nSMase prevents HPV whilst inhibition of aSMase may prevent dysfunction associated with ARDS/sepsis. Thus, these data suggest both nSMase and aSMase are new potential therapeutic targets in the treatment of PH and ARDS/sepsis. The purpose of this application is therefore to fully investigate the role of SMase in the intracellular signaling of hypoxia and inflammation in pulmonary vessels. Secondly, I will investigate associations in SMase activity and gene polymorphisms in tissue from COPD patients with or without PH. This approach will enable us to both identify new treatment targets and potential genetic markers predictive of susceptibility to PH.
Wissenschaftliches Gebiet
Aufforderung zur Vorschlagseinreichung
FP7-PEOPLE-2009-RG
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
MC-ERG - European Re-integration Grants (ERG)Koordinator
28040 Madrid
Spanien